Skip to main content

Predictix ™ - a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report on the efficacy of antidepressants and their side effects

Project description

An innovative platform revolutionises the treatment of depression

Depression is one of the most significant types of mental disorders and causes of disability worldwide. The World Health Organisation and the European Commission are constantly taking measures to ensure access to mental health services without unfair financial barriers and treatments based on both efficiency and economic equity. The EU-funded Predictix project will introduce a user-friendly platform that analyses genomic, clinical and demographic data to generate a personalised report on the efficacy of antidepressants and their side effects. Through Predictix, medical practitioners will have up-to-date and accurate information on each case to improve and customise the care each patient receives.

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

TALIAZ LTD
Address
2 Prof. Yehezkel Kaufmann Street Textile Center, 15Th Floor
6801294 Tel-aviv
Israel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 482 016,25